Search

Your search keyword '"Federico Segura"' showing total 11 results
Start Over Author "Federico Segura" Topic medicine.disease
11 results on '"Federico Segura"'

1. Spanish Catheter Ablation Registry. 18th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2018)

Author

José Luis Ibáñez Criado, Aurelio Quesada, Rocío Cózar, Jesús Almendral-Garrote, Pau Alonso-Fernández, Concepción Alonso-Martín, Nelson María Alvarenga-Recalde, Luis Álvarez-Acosta, Miguel Álvarez-López, Ignasi Anguera-Camos, Eduardo Arana-Rueda, María Fe Arcocha-Torres, Miguel Ángel Arias-Palomares, Antonio Asso-Abadía, Gabriel Alejandro Ballesteros-Derbenti, Alberto Barrera-Cordero, Juan Benezet-Mazuecos, Andrés I. Bodegas-Cañas, Josep Brugada-Terradellas, Claudia Cabadés-Rumbeu, María del Pilar Cabanas-Grandío, Sandra Cabrera-Gómez, Lucas R. Cano-Calabria, Silvia del Castillo-Arrojo, Víctor Castro-Urda, Rocío Cózar-León, Ernesto Díaz-Infante, Juan Manuel Durán-Guerrero, Juliana Elices-Teja, María del Carmen Expósito-Pineda, Juan Manuel Fernández-Gómez, Julio Jesús Ferrer-Hita, María Luisa Fidalgo-Andrés, Adolfo Fontenla-Cerezuela, Arcadio García-Alberola, J. Ignacio García-Bolao, Enrique García-Cuenca, Francisco Javier García-Fernández, Ignacio Gil-Ortega, Federico Gómez-Pulido, Juan Manuel Grande-Ingelmo, Eduard Guasch-i-Casany, José M. Guerra-Ramos, Santiago Heras-Herreros, Julio Hernández-Afonso, Benito Herreros-Guilarte, Víctor Manuel Hidalgo-Olivares, Alicia Ibáñez-Criado, José Luis Ibáñez-Criado, Sonia Ibars-Campaña, Miguel Eduardo Jáuregui-Abularach, F. Javier Jiménez-Candil, Javier Jiménez-Díaz, Jesús I. Jiménez-López, Carla Lázaro-Rivera, José Miguel Lozano-Herrera, Alfonso Macías-Gallego, Santiago Magnani-Ragamato, Javier Martínez-Basterra, Ángel Martínez-Brotons, José Luis Martínez-Sande, Gabriel Martín-Sánchez, Roberto Matías-Francés, José Luis Merino-Llorens, Josep Lluis Mont-Girbau, José Moreno-Arribas, Javier Moreno-Planas, Ángel Moya-i-Mitjans, Marta Ortega-Molina, Joaquín Osca-Asensi, Agustín Pastor-Fuentes, Ricardo Pavón-Jiménez, Rafael Peinado-Peinado, Luisa Pérez-Álvarez, Nicasio Pérez-Castellano, Rosa Porro-Fernández, Andreu Porta-Sánchez, Jordi Punti-Sala, Aurelio Quesada-Dorador, Nuria Rivas-Gándara, Gonzalo Rodrigo-Trallero, Felipe José Rodríguez-Entem, Juan Carlos Rodríguez-Pérez, Rafael Romero-Garrido, José Manuel Rubín-López, José Amador Rubio-Caballero, José Manuel Rubio-Campal, Jerónimo Rubio-Sanz, Pablo M. Ruiz-Hernández, Ricardo Salgado-Aranda, Juan Miguel Sánchez-Gómez, Georgia Sarquella-Brugada, Axel Sarrias-Mercé, Jose María Segura-Saint-Gerons, Federico Segura-Villalobos, and Irene Valverde-André

Subjects
Male, Tachycardia, medicine.medical_specialty, Cavotricuspid isthmus, medicine.medical_treatment, Ablation of atrial fibrillation, Cardiology, Catheter ablation, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, Registries, Major complication, Societies, Medical, Retrospective Studies, business.industry, Data Collection, Mortality rate, Arrhythmias, Cardiac, Atrial fibrillation, General Medicine, medicine.disease, Ablation, Surgery, Spain, Catheter Ablation, Female, medicine.symptom, Electrophysiologic Techniques, Cardiac, business
Abstract

Introduction and objectives: This report presents the findings of the 2018 Spanish Catheter Ablation Registry. Methods: Data collection was retrospective. A standardized questionnaire was completed by each of the participating centers. Results: Data sent by 100 centers were analyzed, with a total number of 16,566 ablation procedures performed (the highest historically reported in this registry) for a mean of 165.5 ± 127.9 and a median of 119 procedures per center. The ablation targets most frequently treated were atrial fibrillation (n = 4234; 25.6%), atrioventricular nodal re-entrant tachycardia (n = 3525; 21.3%) and cavotricuspid isthmus (n = 3425; 20.7%). A new peak was observed in the ablation of atrial fibrillation, increasing the distance from the other substrates. The overall success rate was 91%. The rate of major complications was 2.2%, and the mortality rate was 0.04%. A total of 2.1% of the ablations were performed in pediatric patients. Conclusions: The Spanish Catheter Ablation Registry systematically and continuously enrolls the ablation procedures performed in Spain, showing a progressive increase in the number of ablations over the years, with a high success rate and low percentage of complications.

Published
2019
Full Text
View/download PDF

2. Impact of monitoring on detection of arrhythmia recurrences in the ESC-EHRA EORP atrial fibrillation ablation long-term registry

Author

Federico Segura Villalobos, Cécile Laroche, Piotr Kulakowski, Aldo P. Maggioni, Tamás Forster, Carina Blomström-Lundqvist, Oskars Kalejs, Elena Arbelo, Tosho L. Balabanski, Josef Kautzner, Luigi Tavazzi, Massimo Tritto, Nikolaos Dagres, and Josep Brugada

Subjects
Ablation Techniques, medicine.medical_specialty, medicine.medical_treatment, Aftercare, Kaplan-Meier Estimate, Electrocardiography, Recurrence, Physiology (medical), Internal medicine, Atrial Fibrillation, medicine, Humans, Telemetry, Registries, cardiovascular diseases, Monitoring methods, business.industry, Cardiac arrhythmia, Atrial fibrillation, medicine.disease, Ablation, Telephone, Ecg monitoring, Catheter, Electrocardiography, Ambulatory, Cardiology, Cardiac monitoring, Cardiology and Cardiovascular Medicine, business, Holter ecg
Abstract

Aims Monitoring of patients after ablation had wide variations in the ESC-EHRA atrial fibrillation ablation long-term (AFA-LT) registry. We aimed to compare four different monitoring strategies after catheter AF ablation. Methods and results The ESC-EHRA AFA-LT registry included 3593 patients who underwent ablation. Arrhythmia monitoring during follow-up was performed by 12-lead electrocardiogram (ECG), Holter ECG, trans-telephonic ECG monitoring (TTMON), or an implanted cardiac monitoring (ICM) system. Patients were selected to a given monitoring group according to the most extensive ECG tool used in each of them. Comparison of the probability of freedom from recurrences was performed by censored log-rank test and presented by Kaplan–Meier curves. The rhythm monitoring methods were used among 2658 patients: ECG (N = 578), Holter ECG (N = 1874), TTMON (N = 101), and ICM (N = 105). A total of 767 of 2658 patients (28.9%) had AF recurrences during follow-up. Censored log-rank test discovered a lower probability of freedom from relapses, which was detected with ICM compared to TTMON, ECG, and Holter ECG (P Conclusion Comparing all main electrocardiographic monitoring methods in a large patient sample, our results suggest that post-ablation recurrences of AF are significantly underreported by TTMON, ECG, and Holter ECG. The ICM estimates AF ablation recurrences most reliably and should be a preferred mode of monitoring for trials evaluating novel AF ablation techniques.

Published
2019
Full Text
View/download PDF

3. Impact of body mass index on the outcome of catheter ablation of atrial fibrillation

Author

Glover, B. M., Hong, K. L., Dagres, Arbelo, Laroche, Riahi, Bertini, Mikhaylov, E. N., Galvin, Kiliszek, Pokushalov, Kautzner, Calvo, Blomström-Lundqvist, Brugada, ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry investigators, Committees and Investigators Executive Committee: Nikolaos Dagres, Josep, Brugada, Elena, Arbelo, Luigi, Tavazzi, Carina Blomström Lundqvist, Evgeny, Pokushalov, Josef, Kautzner, Steering Committee (National Coordinators): Clemens Steinwender, Aldo P. Maggioni., Alexandr, Chasnoits, Georges, Mairesse, Tosho, Balabanski, Sam, Riahi, Mostafa, Nawar, Mervat Abul El Maaty, Pekka, Raatikainen, Frederic, Anselme, Thorsten, Lewalter, Turgut, Brodherr, Michalis, Efremidis, Laszlo, Geller, Ben, Glover, Roy, Beinart, Michael, Glikson, Fiorenzo, Gaita, Roin, Rekvava, Oskars, Kalejs, Sergetrines, Zbigniew, Kalarus, Mario Martins Oliveira, Pedro, Adragao, Radu, Ciudin, Evgeny, Mikhaylov, Matjaz, Sinkovec, Julian Perez Villacastin, Carina, Blomström-Lundqvist, Oleg, Sychov, Investigators: Austria, Paul Roberts., Graz, D Daniel Scherr, Martin, Manninger, Bernadette, Mastnak, Innsbruck Otamr Pachinger, Florian, Hintringer, Markus, Stühlinger, Linz Clemens Steinwender, Belgium, Yvoir Olivier Xhaet, Bulgaria, Sofia Tchavdar Shalganov, Milko, Stoyanov, Mihail, Protich, Sofia Vassil Traykov, Daniel, Marchov, Genadi, Kaninski, BELARUS Minsk Alexandr Chasnoits, Czech, Republic, Prague Robert Cihak, Hradec Kralove Ludek Haman, Germany, Frankfurt Boris Schmidt, Julian Chun, K. R., Laura, Perrotta, Stefano, Bordignon, Hamburg Roland Tilz, Hamburg Stephan Willems, Leipzig Gerhard Hindricks, München Turgut Brodherr, Koutsouraki, Ilia S., Denmark, Aalborg Sam Riahi, Bodil Ginnerup Sørensen, Egypt, Cairo Wagdi Galal, Cairo Amir Abdel Wahab, Cairo, S Sherif Mokhtar, Spain, Alicante Ignacio Gil Ortega, Juan Gabriel Martinez Martinez, Badajoz Manuel Doblado Calatrava, Barcelona Roger Villuendas Sabate, Barcelona Lluis Mont Girbau, Bilbao Maria Fe Arcocha, Larraitz, Gaztañaga, Estibaliz, Zamarreño, Granada Miguel Álvarez, Rosa, Macías, LasPalmas de Gran Canaria Federico Segura Villalobos, Juan Carlos Rodríguez Pérez, Madrid Nicasio Perez Castellano, Victoria, Cañadas, Juan, J Gonzalez Ferrer, David, Filgueiras, Madrid Jose Manuel Rubio Campal, Pepa, Sánchez-Borque, Juan, Benezet-Mazuecos, Madrid Jorge Toquero Ramos, Fernandezlozano, Victor Castro Urda, Malaga Alberto Barrera Cordero, Carmen Medina Palomo, Amalio, Ruiz-Salas, Javier, Alzueta, Madrid Rafael Peinado, David, Filqueiras-Rama, Alfonso Gómez Gallanti, Daniel, Garófalo, Pamplona Naiara Calvo, Santander JuanJ ose Olalla Antolin, Sevilla Alonso Pedrote, Eduardo, Arana-Rueda, Lorena, García-Riesco, Finland, Turku Juha Lund, Tampere Pekka Raatikainen, France, Grenoble Pascal Defaye, Peggy, Jacon, Sandrine, Venier, Florian, Dugenet, SaintDenis Olivier Piot, Xavier, Copie, Olivier, Paziaud, Antoine, Lepillier, Saint Etienne Antoine Da Costa, Cécile, Romeyer-Bouchard, Toulouse Serge Boveda, Jean-Paul, Albenque, Nicolas, Combes, Stéphane Combes Marseille AngeFerracci, André, Pisapia, Greece, Athens Demosthenes Katritsis, Athens Konstantinos Letsas, Kostas, Vlachos, Louiza, Lioni, Vassilikos, Thessaloniki Vassilios P., Hungary, Budapest Laszlo Geller, Nándor, Szegedi, Gábor, Széplaki, Tamás, Tahin, Debrecen Zoltan Csanadi, Gabor, Sandorfi, Alexandra, Kiss, Edina, Nagy-Balo, Szeged Laszlo Saghy, Ireland, Glover, Dublin Benedict M., Joseph, Galvin, Edward, Keelan, Israel, Ramat Roy Beinart, Eyal, Nof, Italy, Acquaviva delle Fonti Massimo Grimaldi, Federico, Quadrini, Antonio Di Monaco, Federica, Troisi, Castellanza Massimo Tritto, Elvira, Renzullo, Antonio, Sanzo, Domenico, Zagari, Cotignola Carlo Pappone, Crema Pietro Maria Giovanni Agricola, Milano Paolo Della Bella, Napoli Giuseppe Stabile, Assunta, Iuliano, Pisa Maria Grazia Bongiorni, Roma Leonardo Calo, Ermenegildo de Ruvo, Sciarra, L, Torino Matteo Anselmino, Federico, Ferraris, Varese Roberto De Ponti, Raffaella, Marazzi, Doni, Lorenzo A., Kazakhstan, Almaty Roin Rekvava, Anna, Kim, Latvia, Riga Oskars Kalejs, Netherlands, Breda Sander Molhoek, Groningen Isabelle Van Gelder, Michiel, Rienstra, Leiden Serge Trines, Compier, Marieke G., Maastricht Laurent Pison, Crijns, Harry J., Kevin, Vernooy, Justin, Luermans, Rotterdam, Lucjordaens, Natasja de Groot, Tamas, Szili-Torok, Rohit, Bhagwandien, Zwolle Arif Elvan, Thomas, Buist, Pim, Gal, Poland, Lodz Andrzej Lubinski, Gdansk Tomasz Krolak, Katowice Seweryn Nowak, Katarzyna, Mizia-Stec, Anna Maria Wnuk-Wojnar, Krakow Jacek Lelakowski, Szczecin Jaroslaw Kazmierczak, Warszawa Piotr Kulakowski, Jakub, Baran, Warszawa Grzegorz Opolski, Marek, Kiliszek, Piotr, Lodziński, Sonia, Borodzicz, Paweł, Balsam, Poznan Krzysztof Blaszyk, Warszawa Mariusz Pytkowski, Rafal, Kuteszko, Jan, Ciszewski, Wroclaw Artur Fuglewicz, Zabrze Zbigniew Kalarus, Aleksandra, Woźniak, Karolina, Adamczyk, Portugal, Carnaxide Lisboa Pedro Adragao, Lisboa Pedro Cunha, Romania, Iasi Mihaela Grecu, Grigore, Tinica, Cluj-Napoca Lucian Muresan, Radu, Rosu, Russian, Federation, Kemerovo Egor Khomenko, Khanty-Mansiysk Nikita Scharikov, Krasnoyarsk Dmitry Zamanov, Krasnoyarsk Evgenii Kropotkin, Novosibirsk Evgeny Pokushalov, Alexander, Romanov, Sevda, Bayramova, Mikhaylov, Saint-Petersburg Evgeny N., Lebedev, Dmitry S., Patsouk, Anna V., Saint-Petersburg Sergey Yashin, Saint-Petersburg Dmitry Kryzhanovskiy, Saransk Vyacheslav Bazayev, Surgut Denis Morgunov, Ilya, Silin, Tomsk Sergey Popov, Tyumen Vadim Kuznetsov, Swedon, Linköping Anders Jönsson, Lund Pyotr Platonov, Fredrik, Holmqvist, Ole, Kongstad, Shiwenyuan, Umeå Niklas Höglund, Uppsala Helena Malmborg, David, Mörtsell, Slovenia, Ljubljana Matjaz Sinkovec, Andrej, Pernat, United, Kingdom, Southampton John Morgan, Paul, Roberts, Greenwood, Elizabeth F., Fletcher, Lisa L., Ukraine, Donetsk Tetiana Kravchenko, Kiev Alexander Doronin, Maryna, Meshkova, Odessa Iurii Karpenko, Alex, Goryatchiy, Anna, Abramova., UCL - SSS/IREC/MONT - Pôle Mont Godinne, and UCL - (MGD) Service de cardiologie

Subjects
Male, obesity, Fluoroscopy/methods, medicine.medical_treatment, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Comorbidity, 030204 cardiovascular system & hematology, Overweight, Body Mass Index, 0302 clinical medicine, Recurrence, Risk Factors, catheter ablation, Atrial Fibrillation, 030212 general & internal medicine, Registries, Correlation of Data, Registries/statistics & numerical data, Atrial fibrillation, Middle Aged, Overweight/diagnosis, Europe, Cardiology, Catheter Ablation, Female, atrial fibrillation, catheter ablation, obesity, Body Mass Index, Aged, Comorbidity, Correlation of Data, Europe, Radiation Dosage, Risk Assessment, Risk Factors, Overweight, Obesity, Recurrence, Risk Reduction Behavior, Atrial Fibrillation, Catheter Ablation, Fluoroscopy, medicine.symptom, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, Catheter Ablation/adverse effects, Catheter ablation, Radiation Dosage, Risk Assessment, NO, Europe/epidemiology, 03 medical and health sciences, Internal medicine, medicine, Humans, Obesity, Aged, business.industry, Radiation dose, nutritional and metabolic diseases, Obesity/diagnosis, medicine.disease, Obstructive sleep apnea, Fluoroscopy, Atrial Fibrillation/epidemiology, business, Body mass index, Risk Reduction Behavior, Follow-Up Studies
Abstract

ObjectivesThe association between obesity and atrial fibrillation (AF) is well-established. We aimed to evaluate the impact of index body mass index (BMI) on AF recurrence at 12 months following catheter ablation using propensity-weighted analysis. In addition, periprocedural complications and fluoroscopy details were examined to assess overall safety in relationship to increasing BMI ranges.MethodsBaseline, periprocedural and follow-up data were collected on consecutive patients scheduled for AF ablation. There were no specific exclusion criteria. Patients were categorised according to baseline BMI in order to assess the outcomes for each category.ResultsAmong 3333 patients, 728 (21.8%) were classified as normal (BMI 2), 1537 (46.1%) as overweight (BMI 25.5–29.0 kg/m2) and 1068 (32.0%) as obese (BMI ≥30.0 kg/m2). Procedural duration and radiation dose were higher for overweight and obese patients compared with those with a normal BMI (p=0.002 and p2led to a 1.2-fold increased likelihood of experiencing recurrent AF at 12-months follow-up as compared with overweight patients (HR 1.223; 95% CI 1.047 to 1.429; p=0.011), while no significant correlation was found between overweight and normal BMI groups (HR 0.954; 95% CI 0.798 to 1.140; p=0.605) and obese versus normal BMI (HR 1.16; 95% CI 0.965 to 1.412; p=0.112).ConclusionsPatients with a baseline BMI ≥30 kg/m2have a higher recurrence rate of AF following catheter ablation and therefore lifestyle modification to target obesity preprocedure should be considered in these patients.

Published
2019
Full Text
View/download PDF

4. Risk stratification of cardiovascular and heart failure hospitalizations using integrated device diagnostics in patients with a cardiac resynchronization therapy defibrillator

Author

Giuseppe Boriani, Lorenza Mangoni di S. Stefano, Renato Pietro Ricci, Haran Burri, Federico Segura Villalobos, Antoine Da Costa, Nicolas Clementy, Gabriele Boscolo, Stefano Favale, Vinod Sharma, and Aurelio Quesada

Subjects
Male, medicine.medical_treatment, 030204 cardiovascular system & hematology, law.invention, Cardiac Resynchronization Therapy, 0302 clinical medicine, Randomized controlled trial, law, 030212 general & internal medicine, ddc:616, Cardiac resynchronization therapy, virus diseases, Middle Aged, Telemedicine, Defibrillators, Implantable, Europe, Hospitalization, Cardiology, Female, Cardiology and Cardiovascular Medicine, Algorithms, Integrated diagnostics, medicine.medical_specialty, Heart failure, Risk Assessment, 03 medical and health sciences, Physiology (medical), Internal medicine, Post-hoc analysis, medicine, Humans, Cardiac Resynchronization Therapy Devices, Risk stratification, Aged, Monitoring, Physiologic, Heart Failure, Remote monitoring, Symptoms, business.industry, Reproducibility of Results, medicine.disease, Triage, Clinical trial, Relative risk, Remote Sensing Technology, business
Abstract

Aims Cardiac resynchronization therapy defibrillators (CRT-D) are able to monitor various parameters that may be combined by an automatic algorithm to provide a heart failure risk status (HFRS). We sought to validate the HFRS for stratifying patient risk, evaluate its association with heart failure (HF) symptoms, and investigate its utility for triage of automatic alerts. Methods and results Data from 722 patients included in the MORE-CARE trial were analysed in a post hoc analysis. A high HFRS was associated with a significantly increased risk of admission over the next 30 days with a relative risk for cardiovascular hospitalization (CVH) of 4.5 (95% CI: 3.1-6.6, P

Published
2017
Full Text
View/download PDF

5. Hypertrophic Cardiomyopathy Without Ventricular Hypertrophy: Usefulness of Genetic and Pathological Study in Preventing Sudden Death

Author

Haridian Mendoza-Lemes, Juan Carlos Rodríguez-Pérez, Ana Isabel Hernández-Guerra, Federico Segura-Villalobos, Fernando Wanguemert-Pérez, and Roberto Barriales-Villa

Subjects
medicine.medical_specialty, Fatal outcome, medicine.diagnostic_test, business.industry, Hypertrophic cardiomyopathy, General Medicine, 030204 cardiovascular system & hematology, medicine.disease, Sudden death, 03 medical and health sciences, 0302 clinical medicine, Ventricular hypertrophy, Internal medicine, medicine, Cardiology, 030212 general & internal medicine, business, Death sudden cardiac, Pathological, Genetic testing
Published
2017
Full Text
View/download PDF

6. Spanish Results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II)

Author

Fernando Pérez, Agustín Pastor, Kenneth Dickstein, Federico Segura, Marta Pombo, Sara Moreno, José Enero, José Martínez-Ferrer, Adolfo Fontenla, Pablo Peñafiel, Carmen Expósito, José Moríñigo, Julia Martín-Fernández, Jordi Mercé, Vicente Bertomeu-González, José Ormaetxe, Lorena García-Riesco, Rafael Peinado, Alejandro Bellver, Ángel Martínez-Brótons, Ricardo Pavón, Alfonso Macías, Camilla Normand, Antonio Peláez, José Luis Ibáñez, Juan José González-Ferrer, Jaume Francisco-Pascual, Angel Arenal, Óscar Cano, Cecilia Linde, Roger Villuendas, Bieito Campos, David Calvo, Javier García-Seara, Francisco-José García-Almagro, Ignacio Fernández-Lozano, Francisco Mazuelos, Miguel A. Alvarez, and José María Tolosana

Subjects
Male, medicine.medical_specialty, genetic structures, medicine.medical_treatment, Cardiac resynchronization therapy, Heart failure, 030204 cardiovascular system & hematology, New york heart association, Cardiac Resynchronization Therapy, 03 medical and health sciences, Electrocardiography, 0302 clinical medicine, Interquartile range, Internal medicine, Surveys and Questionnaires, Hospital discharge, medicine, Humans, Aged, Retrospective Studies, Left bundle branch block, business.industry, Arrhythmias, Cardiac, General Medicine, Middle Aged, medicine.disease, Europe, Spain, Baseline characteristics, Cardiology, cardiovascular system, Female, Implant, Cardiac resynchronization therapy, Heart failure, Insuficiencia cardiaca, Terapia de resincronización cardiaca, Morbidity, business
Abstract

Introduction and objectives: We describe the results for Spain of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II) and compare them with those of the other participating countries. Methods: We included patients undergoing CRT device implantation between October 2015 and December 2016 in 36 participating Spanish centers. We registered the patients' baseline characteristics, implant procedure data, and short-term follow-up information until hospital discharge. Results: Implant success was achieved in 95.9%. The median [interquartile range] annual implantation rate by center was significantly lower in Spain than in the other participating countries: 30 implants/y [21-50] vs 55 implants/y [33-100]; P = .00003. In Spanish centers, there was a lower proportion of patients >= 75 years (27.9% vs 32.4%; P = .0071), a higher proportion in New York Heart Association functional class II (46.9% vs 36.9%; P < .00001), and a higher percentage with electrocardiographic criteria of left bundle branch block (82.9% vs 74.6%; P < .00001). The mean length of hospital stay was significantly lower in Spanish centers (5.8 +/- 8.5 days vs 6.4 +/- 11.6; P < .00001). Spanish patients were more likely to receive a quadripolar LV lead (74% vs 56%; P < .00001) and to be followed up by remote monitoring (55.8% vs 27.7%; P = 75 years received a CRT device, while more patients were in New York Heart Association functional class II and had left bundle branch block. In addition, the length of hospital stay was shorter, and there was greater use of quadripolar LV leads and remote CRT monitoring. (C) 2018 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.

Published
2019

7. Spanish Catheter Ablation Registry. 17th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2017)

Author

F. Javier García-Fernández, José Luis Ibáñez Criado, Aurelio Quesada Dorador, Miguel Álvarez-López, Jesús Almendral, Concepción Alonso, Pau Alonso-Fernández, Nelson Alvaralenga, Luis Álvarez-Acosta, Ignasi Anguera, María Fe Arcocha, Miguel Ángel Arias, Antonio Asso, Alberto Barrera-Cordero, Gabriel Ballesteros, Juan Benezet-Mazuecos, Andrés Bodegas-Cañas, Josep Brugada, Claudia Cabadés Lucas Cano-Calabria, Eduardo Caballero-Dorta, Pilar Cabanas-Grandío, Sandra Cabrera, Víctor Castro, Rocío Cózar, Ernesto Díaz-Infante, Manuel Doblado, Juliana Elices, María del Carmen Expósito-Pineda, Juan Manuel Fernández-Gómez, María Luisa Fidalgo, Adolfo Fontenla, Arcadio García-Alberola, Ignacio Gil-Ortega, Federico Gómez-Pulido, Mar González-Vasserot, Ángel Grande, José M. Guerra-Ramos, Julio Hernández-Afonso, Santiago Heras-Herreros, Víctor Manuel Hidalgo-Olivares, José Luis Ibáñez-Criado, Alicia Ibáñez-Criado, Sonia Ibars, Miguel Jauregui, Jesús Jiménez, Javier Jiménez-Díaz, Javier Jiménez-Candil, Carla Lázaro-Rivera, Francisco Mazuelos, Santiago Magnani, Javier Martínez-Basterra, Alfonso Macías, Ángel Martínez-Brotons, José Luis Martínez-Sande, Roberto Matía-Francés, Pablo Moriña, Ángel Moya, Lluis Mont, José Moreno-Arribas, Javier Moreno-Planas, Josep Navarro-Manchón, Marta Ortega-Molina, Joaquín Osca, Agustín Pastor, Ricardo Pavón-Jiménez, Alonso Pedrote, Rafael Peinado, Luisa Pérez-Álvarez, Nicasio Pérez-Castellano, Javier Pindado, Rosa Porro-Fernández, Jordi Punti-Sala, Aurelio Quesada, Nuria Rivas-Gándara, Gonzalo Rodrigo-Trallero, Ivo Roca, Felipe Rodríguez-Entem, Juan Carlos Rodríguez-Pérez, Enrique Rodríguez-Font, Pablo Ruiz-Hernández, José Manuel Rubín, José Manuel Rubio-Campal, Amador Rubio-Caballero, Jerónimo Rubio-Sanz, Ricardo Salgado-Aranda, Axel Sarrias, Georgia Sarquella-Brugada, Elena Esteban-Paul, and Federico Segura

Subjects
Tachycardia, Cavotricuspid isthmus, medicine.medical_specialty, medicine.medical_treatment, Cardiology, Catheter ablation, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, 030212 general & internal medicine, Major complication, Registries, Societies, Medical, Retrospective Studies, business.industry, Mortality rate, Atrial fibrillation, Arrhythmias, Cardiac, General Medicine, Ablation, medicine.disease, Surgery, Catheter, Spain, Catheter Ablation, medicine.symptom, Morbidity, business, Electrophysiologic Techniques, Cardiac
Abstract

Introduction and objectives: This report describes the findings of the 2017 Spanish Catheter Ablation Registry. Methods: Data collection was retrospective. A standardized questionnaire was completed by each of the participating centers. Results: A total of 15 284 ablation procedures were performed by 98 institutions (the highest number of ablations and institutions historically reported in this registry), with a mean of 156 ± 126 and a median of 136 procedures per center. For the first time, the most frequently treated ablation target was atrial fibrillation (n = 3457; 22.6%), followed by cavotricuspid isthmus (n = 3449; 22.5%) and atrioventricular nodal re-entrant tachycardia (n = 3429; 22.4%). The overall success rate was 87%. The rate of major complications was 2.6%, and the mortality rate was 0.09%. The percentage of procedures performed without fluoroscopic support increased to 6% of all ablations, and 2.3% of all ablations were performed in pediatric patients. Conclusions: The Spanish Ablation Catheter Registry systematically and uninterruptedly collects data on the ablation procedures performed in Spain, revealing that both the number of ablations and the number of centers performing them has progressively increased, while maintaining a high success rate and a low percentage of complications.

Published
2018

8. Safety and Predictors of Complications with a New Accelerated Dobutamine Stress Echocardiography Protocol

Author

José Alberto San Román, José Ramón Ortega, Roman Arnold, Diego Jimenez, Itziar Gómez, Francisco Fernández-Avilés, Marta Pinedo, Andrés Carnero, Matías Pérez-Paredes, Federico Segura, Ricardo Sanz-Ruiz, María Jesús Rollán, and Ana Cristina Muñoz

Subjects
Atropine, Male, medicine.medical_specialty, Time Factors, Dobutamine stress echocardiography, Blood Pressure, Muscarinic Antagonists, Risk Assessment, Coronary artery disease, Electrocardiography, Predictive Value of Tests, Dobutamine, Internal medicine, Tremor, Heart rate, medicine, Humans, Radiology, Nuclear Medicine and imaging, Myocardial infarction, Aged, Ejection fraction, Dose-Response Relationship, Drug, business.industry, Baseline systolic blood pressure, Headache, Arrhythmias, Cardiac, Nausea, Adrenergic beta-Agonists, Middle Aged, medicine.disease, Logistic Models, Echocardiography, Heart failure, Hypertension, Ventricular fibrillation, Tachycardia, Ventricular, Cardiology, Drug Evaluation, Female, Hypotension, Cardiology and Cardiovascular Medicine, business, Echocardiography, Stress
Abstract

This study sought to document the safety of a new accelerated dobutamine-atropine stress echocardiography protocol and to analyze its complications.Dobutamine-atropine stress echocardiography studies were performed using an incremental dobutamine infusion protocol from 20 to 40 microg/kg/min in 3-minute stages and followed by atropine.A total of 962 patients were included. Mean age was 64 +/- 11 years and 584 were male (61%). Mean ejection fraction was 62 +/- 10%. Complications included hypertensive responses in 66 patients (7%), arrhythmias in 26 (2.7%), and symptomatic hypotension in 16 (1.7%). No patient developed heart failure, acute myocardial infarction, ventricular fibrillation, or died. The independent predictors of hypertensive responses were age, baseline systolic blood pressure, and treatment with nitrates. The independent predictors of arrhythmias were history of hypertension, previous coronary artery disease, and baseline heart rate.This accelerated dobutamine-atropine stress echocardiography protocol is safe in a low-risk population and has a rate of complications similar to that reported for the standard protocol.

Published
2008
Full Text
View/download PDF

9. Diagnostic Approach to Unexplained Cardiac Arrest (from the FIVI-Gen Study)

Author

Juan R. Gimeno, Julia Fernández Pastor, Luis Tercedor, Juan Jiménez-Jáimez, Rafael Peinado, Juan José Sánchez Muñoz, Francisco Mazuelos, Diana Domingo, Rocío Picón Heras, Federico Segura, Miguel Álvarez, Esther Zorio Grima, Pablo Moriña, Rocío Cózar, Martin Ortiz-Genga, and Lorenzo Monserrat

Subjects
Adult, Male, Cardiac Catheterization, medicine.medical_specialty, Adolescent, Epinephrine, Heart Diseases, Heart disease, Long QT syndrome, Catecholaminergic polymorphic ventricular tachycardia, Cohort Studies, Electrocardiography, Young Adult, Clinical Protocols, Internal medicine, medicine, Humans, Family, Genetic Testing, Sympathomimetics, Flecainide, Brugada Syndrome, Genetic testing, Brugada syndrome, medicine.diagnostic_test, business.industry, Arrhythmias, Cardiac, Short QT syndrome, Middle Aged, medicine.disease, Penetrance, Heart Arrest, Long QT Syndrome, Cross-Sectional Studies, Echocardiography, Tachycardia, Ventricular, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Anti-Arrhythmia Agents, medicine.drug
Abstract

Unexplained cardiac arrest (UCA) can be caused by low-penetrance genetic disorders. The aim of this cross-sectional study is to assess the usefulness of a new diagnostic protocol: Thirty-five patients were recruited from 9 Spanish centers. Electrocardiogram, echocardiogram, and coronary catheterization were used to rule out electrical or structural heart disease in all subjects. Patients underwent pharmacologic tests with epinephrine and flecainide, followed by assessment of family members using electrocardiogram and echocardiogram, and next-generation genetic sequencing to analyze 126 genes if all the other test results were negative. A firm diagnosis of channelopathy required phenotypic proof of the condition in unmasking tests, the presence of a pathogenic variant consistent with the phenotype observed, and/or co-segregation of the mutation found in a family member's phenotype. A firm diagnosis was made in 18 cases. The diagnoses were 7 Brugada syndrome, 5 catecholaminergic polymorphic ventricular tachycardia, 3 long QT syndrome, 2 early repolarization syndrome, and 1 short QT syndrome. Pharmacologic testing was the most frequent method of diagnosis. In 5 cases, the diagnosis was made based on positive genetic testing without phenotypic alterations. In conclusion, this sequential diagnostic protocol allows diagnoses to be made in approximately half of the UCA cases. These diagnoses are low clinical penetrance channelopathies. If interpreted carefully, genetic tests can be a useful tool for diagnosing UCA without a phenotype. (C) 2015 Elsevier Inc. All rights reserved.

Published
2015

10. 1101-64 Six-month intracoronary ultrasound findings following sirolimus-eluting stents for the treatment of restenosis-prone coronary lesions

Author

Federico Segura, Miguel Romero, Juan Herrador, JoséSuárez de Lezo, José L. Segura, Isabel Ureña, Enrique Hernández, Manuel Pan, Francisco Melián, Antonio Delgado, Alfonso Medina, and Djordje Pavlovic

Subjects
medicine.medical_specialty, Restenosis, business.industry, Sirolimus, medicine, Intracoronary ultrasound, Radiology, business, medicine.disease, Cardiology and Cardiovascular Medicine, medicine.drug
Published
2004
Full Text
View/download PDF

11. Systematic assesment of patients with unexplained cardiac arrest: results from the FIVI-Gen study

Author

Federico Segura, Luis Tercedor, Rafael Peinado, L. Montserrat, Miguel Álvarez, J. Jimenez Jaimez, Juan R. Gimeno, E. Zorio Grima, Francisco Mazuelos, and P. Morinas

Subjects
Coronary angiography, medicine.medical_specialty, business.industry, Long QT syndrome, Cardiomyopathy, Hypertrophic cardiomyopathy, medicine.disease, Catecholaminergic polymorphic ventricular tachycardia, QT interval, Internal medicine, medicine, Cardiology, Cardiology and Cardiovascular Medicine, business, Flecainide, medicine.drug, Brugada syndrome
Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results